Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9293492 | Contemporary Clinical Trials | 2005 | 7 Pages |
Abstract
After participating in a RCT assessing anti-COX-2 NSAIDs, many patients return with less frequency, or do not return at all to their regular rheumatologic visit. Although a high number of tablets of the investigational drug and a low frequency of protocol visits may be contributors to patient loss to FU, investigators should consider that personal situations not related to the RCTs may also influence patients' return to consultation in the private setting.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ingrid Strusberg, Ana M. Bertoli, Mariela Ramos, Gonzalo Fierro, Ruth Pizzolato, Ida Exeni, Alberto M. Strusberg,